Previous 10 | Next 10 |
2023-06-09 09:26:24 ET The Biden administration on Friday published a list of Medicare Part B drugs that will be subject to inflation penalties for Q3 2023, including some of the products from AbbVie ( NYSE: ABBV ) and Amgen ( NASDAQ: AMGN ) in the list of 43 medications. ...
2023-06-07 12:43:08 ET Regeneron Pharmaceuticals, Inc. (REGN) Jefferies Global Healthcare Conference Call June 7, 2023 08:30 ET Company Participants Ryan Crowe - Vice President, Investor Relations Bolanle Akinlade - Senior Vice President, Clinical Development, Immuno...
2023-06-01 08:26:11 ET Roche Holding AG ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) is looking for an outright sale or closure of a California manufacturing plant focused on biological drug production, Reuters reported Thursday, citing emails sent to employees. The Swiss pharma giant bo...
2023-05-30 15:18:10 ET Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 4th Annual Oncology Innovation Summit May 30, 2023 12:30 PM ET Company Participants Izzy Lowy - SVP, Solid Organ Oncology Development Andres Sirulnik - SVP, Translational & Clinical Sciences, ...
71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200 mg dose, per new data to be shared in an oral session at ASCO Benefit also observed across prespecified subgroups, including patients with high disease burden and ag...
Data demonstrate objective response rates from 56% to 63% across three independent cohorts of advanced melanoma patients – about double the rate historically seen with anti-PD-1 alone in similar settings – per trial results to be presented in an oral session at ASCO Clinic...
Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant reduction in moderate or severe acute exacerbations by 30% compared to placebo Dupixent is the first and only investigational biologic for COPD that has significantly improved lung funct...
High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023 PR Newswire $75,000 Top Award Goes to 17 -year-old Kaitlyn Wang for breakthrough innovation to accelerate exoplanet discovery in the largest ...
2023-05-19 15:00:19 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
TARRYTOWN, N.Y. and WASHINGTON, D.C., May 19, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Society for Science (the Society) announced that Kaitlyn Wang, 17, of San José, CA, won the $75,000 top award in the 2023 Regeneron I...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...